{{Rsnum
|rsid=1143684
|Gene=NQO2
|Chromosome=6
|position=3010156
|Orientation=plus
|GMAF=0.1979
|Gene_s=NQO2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 6.2 | 32.7 | 61.1
| HCB | 17.5 | 30.7 | 51.8
| JPT | 8.0 | 57.5 | 34.5
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 15.8 | 84.2
| CHB | 17.5 | 30.7 | 51.8
| CHD | 11.1 | 42.6 | 46.3
| GIH | 7.9 | 36.6 | 55.4
| LWK | 0.0 | 1.8 | 98.2
| MEX | 1.7 | 43.1 | 55.2
| MKK | 0.0 | 11.5 | 88.5
| TSI | 8.8 | 40.2 | 51.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=21351093
|Title=Association of superoxide dismutases and NAD(P)H quinone oxidoreductases with prognosis of patients with breast carcinomas
}}

{{PMID Auto
|PMID=18538895
|Title=Investigation of a functional quinine oxidoreductase (NQO2) polymorphism and cognitive decline.
}}

{{PMID Auto
|PMID=18698231
|Title=Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissues.
|OA=1
}}

{{PMID Auto
|PMID=20966810
|Title=Superoxide dismutase and nicotinamide adenine dinucleotide phosphate: quinone oxidoreductase polymorphisms and pancreatic cancer risk.
}}

{{PMID Auto
|PMID=21946896
|Title=Two minor NQO1 and NQO2 alleles predict poor response of breast cancer patients to adjuvant doxorubicin and cyclophosphamide therapy.
}}

{{GET Evidence
|gene=NQO2
|aa_change=Leu47Phe
|aa_change_short=L47F
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1143684
|overall_frequency_n=9092
|overall_frequency_d=10758
|overall_frequency=0.845138
|n_genomes=54
|n_genomes_annotated=0
|n_haplomes=100
|n_articles=0
|n_articles_annotated=0
|nblosum100=0
|autoscore=0
|webscore=N
}}

{{PMID Auto
|PMID=24631540
|Title=The two common polymorphic forms of human NRH-quinone oxidoreductase 2 (NQO2) have different biochemical properties
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}